Clinical/Research Interests

Specialty:

Center/Program Affiliation:

Address:

Phone:

Education:

Internships:

Residency:

Fellowships:

Board Certifications:

Professional Memberships:

Select Recent Publications:

Taylor, DS, Y Lee, CA Sieff, A Homans, L Garrison, B Guinan. Phase I/II trial of PIXY321 (granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein) for the treatment of inherited and acquired bone marrow failure syndromes. British Journal of Hematology 103: 304-307, 1998.

Taylor DS, JP Laubach, DG Nanthan, B Mathey-Prevot. Cooperation between CBF and adjacent promoter elements contributes to the tissue specific expression of interleukin 3. Journal of Biological Chemistry 271: 14020-14027, 1996.

Cameron, S, DS Taylor, EC Tepas, NA Speck, B Mathey-Prevot. Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting. Blood 83:2851-2859, 1994.

Taylor DS, PC Nowell, J Kornbluth. Anti-HLA class I antibodies inhibit the T cell independent proliferation of human B lymphocytes. J Immunol 139: 1792-1796, 1987.

Taylor DS, PC Nowell, J Kornbluth. Functional role of HLA class I molecules in human T lymphocyte activation and proliferation. Proc Natl Acad Sci USA 83: 4446-4450, 1986.

Taylor DS, JA Kern, PC Nowell. IL2 alone is mitogenic for only Tac-positive lymphocytes in human peripheral blood. J Immunol 136: 1620-1624, 1986.

Hannam-Harris AC, DS Taylor, PC Nowell. Cyclosporin A directly inhibits human B cell proliferation by more than a single mechanism. J Leukocyte Biol 38: 231-239, 1985.

Taylor DS, JC Reed, PC Nowell. Stimulation and inhibition of human T cell subsets by wheat germ agglutinin. J Immunol 134: 3756-3761, 1985.